Compare Stocks

Date Range: 

 PerkinElmerWatersAvantorBio-Rad Laboratories
SymbolNYSE:PKINYSE:WATNYSE:AVTRNYSE:BIO
Price Information
Current Price$139.44$315.89$30.86$596.38
52 Week RangeBuyHoldBuyBuy
MarketRank™
Overall Score1.91.32.01.5
Analysis Score1.40.93.52.5
Community Score2.42.03.02.4
Dividend Score1.70.00.00.0
Ownership Score1.71.71.70.8
Earnings & Valuation Score2.51.91.91.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuy
Consensus Price Target$141.73$251.25$34.87$700.00
% Upside from Price Target1.64% upside-20.46% downside12.98% upside17.37% upside
Trade Information
Market Cap$15.63 billion$19.49 billion$17.96 billion$17.75 billion
Beta1.190.971.840.83
Average Volume998,572372,2524,407,595197,555
Sales & Book Value
Annual Revenue$2.88 billion$2.41 billion$6.04 billion$2.31 billion
Price / Sales5.428.102.977.68
Cashflow$5.77 per share$16.77 per share$2.00 per share$7.06 per share
Price / Cash24.1618.8415.4584.42
Book Value$25.33 per share($3.36) per share$2.55 per share$192.32 per share
Price / Book5.50-94.0112.103.10
Profitability
Net Income$227.56 million$592.20 million$37.80 million$1.76 billion
EPS$4.10$8.99$0.58$7.06
Trailing P/E Ratio37.8939.34257.175.11
Forward P/E Ratio17.7435.6128.3158.47
P/E Growth0.998.791.07N/A
Net Margins12.74%22.61%2.21%147.91%
Return on Equity (ROE)21.57%-349.31%44.58%3.77%
Return on Assets (ROA)9.61%21.11%6.85%2.74%
Dividend
Annual Payout$0.28N/AN/AN/A
Dividend Yield0.20%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout Ratio6.83%N/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/A
Debt
Debt-to-Equity Ratio0.46%N/A3.27%N/A
Current Ratio1.35%1.82%2.02%2.36%
Quick Ratio0.96%1.33%1.38%1.71%
Ownership Information
Institutional Ownership Percentage89.44%91.80%84.79%63.03%
Insider Ownership Percentage0.62%1.50%1.90%27.50%
Miscellaneous
Employees14,0007,40012,4008,000
Shares Outstanding112.06 million61.70 million582.14 million29.76 million
Next Earnings Date7/27/2021 (Estimated)7/27/2021 (Estimated)8/4/2021 (Estimated)7/29/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionable
SourceHeadline
Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?Was The Smart Money Right About Bio-Rad Laboratories, Inc. (BIO)?
finance.yahoo.com - May 10 at 7:57 PM
Covid-19 Detection Kits Market Forecast 2026 | BGI, Abbott Laboratories, F. Hoffmann-La Roche, Guangzhou Wondfo Biotech, Qiagen, SeegeneCovid-19 Detection Kits Market Forecast 2026 | BGI, Abbott Laboratories, F. Hoffmann-La Roche, Guangzhou Wondfo Biotech, Qiagen, Seegene
openpr.com - May 6 at 11:45 PM
Bio-Rad Laboratories (NYSE:BIO) Issues FY 2021 Earnings GuidanceBio-Rad Laboratories (NYSE:BIO) Issues FY 2021 Earnings Guidance
americanbankingnews.com - May 6 at 12:10 PM
Bio-Rad launches its Reliance SARS-CoV-2 RT-PCR Assay Kit in EuropeBio-Rad launches its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe
cambridgenetwork.co.uk - May 5 at 10:42 PM
Bio-Rad Ruling Highlights IP Assignment Clause LimitsBio-Rad Ruling Highlights IP Assignment Clause Limits
law360.com - May 5 at 5:42 PM
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $630.13Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $630.13
americanbankingnews.com - May 4 at 11:06 AM
Fed. Circ. OKs ITC Ruling That Bio-Rad Infringed 10x PatentsFed. Circ. OKs ITC Ruling That Bio-Rad Infringed 10x Patents
law360.com - May 1 at 1:08 AM
Bio-Rad Laboratories (NYSE:BIO) Issues Quarterly  Earnings Results, Beats Estimates By $2.71 EPSBio-Rad Laboratories (NYSE:BIO) Issues Quarterly Earnings Results, Beats Estimates By $2.71 EPS
americanbankingnews.com - April 30 at 8:18 PM
Bio-Rad Laboratories (NYSE:BIO) Updates FY 2021 Earnings GuidanceBio-Rad Laboratories (NYSE:BIO) Updates FY 2021 Earnings Guidance
americanbankingnews.com - April 29 at 7:44 PM
Bio-Rad: Q1 Earnings Snapshot | Raleigh News & ObserverBio-Rad: Q1 Earnings Snapshot | Raleigh News & Observer
newsobserver.com - April 29 at 6:40 PM
What are The Major Factors Expected to Limit The Growth Of The High Throughput Screening Market?What are The Major Factors Expected to Limit The Growth Of The High Throughput Screening Market?
marketwatch.com - April 28 at 9:43 AM
In Situ Hybridization (ISH) Market to Grow by USD 475.05 Million During 2021-2025|TechnavioIn Situ Hybridization (ISH) Market to Grow by USD 475.05 Million During 2021-2025|Technavio
prnewswire.com - April 27 at 11:58 PM
What are The Major Factors Expected to Limit The Growth Of The Healthcare Life Science & Chemical Instrumentation Market?What are The Major Factors Expected to Limit The Growth Of The Healthcare Life Science & Chemical Instrumentation Market?
marketwatch.com - April 27 at 1:58 PM
Research Antibodies & Reagents Market Projections and Future Opportunities Recorded for the Period until 2025| Danaher, Bio-Rad LaboratoriesResearch Antibodies & Reagents Market Projections and Future Opportunities Recorded for the Period until 2025| Danaher, Bio-Rad Laboratories
marketwatch.com - April 27 at 1:58 PM
Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 VaccineModerna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine
technologynetworks.com - April 27 at 1:58 PM
Bio-Rad Laboratories B earnings preview: what to expectBio-Rad Laboratories B earnings preview: what to expect
markets.businessinsider.com - April 27 at 1:58 PM
Global Infectious Disease Diagnostics Markets Report 2020-2027 - Shift in Focus from Centralized Laboratories to POC Testing ServicesGlobal Infectious Disease Diagnostics Markets Report 2020-2027 - Shift in Focus from Centralized Laboratories to POC Testing Services
in.finance.yahoo.com - April 27 at 8:57 AM
North America Hemoglobin Testing Market Analysis by Region Analysis and Business Development, By 2025North America Hemoglobin Testing Market Analysis by Region Analysis and Business Development, By 2025
marketwatch.com - April 27 at 12:14 AM
In Vitro Toxicology Testing Market Expected to Experience Bolstering Sales during Forecast Period, 2018 to 2026In Vitro Toxicology Testing Market Expected to Experience Bolstering Sales during Forecast Period, 2018 to 2026
kyn24.com - April 25 at 8:26 AM
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Weeks ReleaseBio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
finance.yahoo.com - April 22 at 2:33 PM
Bio-Rad Laboratories, Inc.: Bio-Rad Benefiting From Record Flow-Through Profits From Sartorius; Diagnostic Recovery UnderwayBio-Rad Laboratories, Inc.: Bio-Rad Benefiting From Record Flow-Through Profits From Sartorius; Diagnostic Recovery Underway
finance.yahoo.com - April 22 at 9:31 AM
Bio-Rad Laboratories (BIO) to Release Quarterly Earnings on ThursdayBio-Rad Laboratories (BIO) to Release Quarterly Earnings on Thursday
americanbankingnews.com - April 22 at 3:16 AM
qRT-PCR Market 2021 Top Companies report covers are Thermo Fisher Scientific (U.S.),Bio-Rad Laboratori and Market Share, Demand Forecast to 2025qRT-PCR Market 2021 Top Companies report covers are Thermo Fisher Scientific (U.S.),Bio-Rad Laboratori and Market Share, Demand Forecast to 2025
marketwatch.com - April 21 at 2:03 PM
Quality Control in CAR T-Cell Manufacturing Using ddPCRQuality Control in CAR T-Cell Manufacturing Using ddPCR
technologynetworks.com - April 20 at 9:33 AM
Capillary Electrophoresis Equipment Market Latest Report: Top Company Profiles, CAGR, Production And Sales Estimations and Forecast 2026Capillary Electrophoresis Equipment Market Latest Report: Top Company Profiles, CAGR, Production And Sales Estimations and Forecast 2026
marketwatch.com - April 19 at 12:29 PM
DateCompanyBrokerageAction
2/3/2021PerkinElmerCitigroupBoost Price Target
1/7/2021PerkinElmerWells Fargo & CompanyUpgrade
12/11/2020PerkinElmerCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/11/2020PerkinElmerSmith Barney CitigroupBoost Price Target
12/2/2020PerkinElmerThe Goldman Sachs GroupInitiated Coverage
11/9/2020PerkinElmerKeyCorpInitiated Coverage
11/9/2020PerkinElmerNeedham & Company LLCBoost Price Target
10/29/2020PerkinElmerRobert W. BairdBoost Price Target
8/10/2020PerkinElmerBMO Capital MarketsBoost Price Target
7/29/2020PerkinElmerJPMorgan Chase & Co.Boost Price Target
7/29/2020PerkinElmerStifel NicolausBoost Price Target
7/29/2020PerkinElmerCfraUpgrade
5/7/2020PerkinElmerUBS GroupBoost Price Target
5/6/2021WatersSVB LeerinkBoost Price Target
12/17/2020WatersCleveland ResearchUpgrade
4/29/2020WatersBank of AmericaLower Price Target
5/5/2021AvantorRaymond JamesBoost Price Target
5/5/2021AvantorMorgan StanleyBoost Price Target
5/5/2021AvantorCredit Suisse GroupBoost Price Target
4/29/2021AvantorPiper SandlerBoost Price Target
3/8/2021AvantorBarclaysInitiated Coverage
2/5/2021Bio-Rad LaboratoriesJefferies Financial GroupBoost Price Target
5/9/2019Bio-Rad LaboratoriesDeutsche Bank AktiengesellschaftBoost Price Target
(Data available from 5/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.